IMP A SDB Stock Overview
Engages in the research and distribution of medical implants in Switzerland.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Implantica AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr28.70 |
| 52 Week High | kr33.00 |
| 52 Week Low | kr16.00 |
| Beta | 1.3 |
| 1 Month Change | -0.86% |
| 3 Month Change | -1.03% |
| 1 Year Change | 56.15% |
| 3 Year Change | -71.30% |
| 5 Year Change | n/a |
| Change since IPO | -70.28% |
Recent News & Updates
Recent updates
We're Hopeful That Implantica (STO:IMP A SDB) Will Use Its Cash Wisely
Jul 26
We're Hopeful That Implantica (STO:IMP A SDB) Will Use Its Cash Wisely
Mar 06We Think Implantica (STO:IMP A SDB) Can Easily Afford To Drive Business Growth
Aug 19We Think Implantica (STO:IMP A SDB) Can Easily Afford To Drive Business Growth
May 05We're Not Very Worried About Implantica's (STO:IMP A SDB) Cash Burn Rate
Jan 14We're Hopeful That Implantica (STO:IMP A SDB) Will Use Its Cash Wisely
Sep 26Implantica (STO:IMP A SDB) Is In A Strong Position To Grow Its Business
Jan 08
Shareholder Returns
| IMP A SDB | SE Medical Equipment | SE Market | |
|---|---|---|---|
| 7D | -2.4% | -1.9% | -1.5% |
| 1Y | 56.1% | -5.5% | 12.9% |
Return vs Industry: IMP A SDB exceeded the Swedish Medical Equipment industry which returned -5.5% over the past year.
Return vs Market: IMP A SDB exceeded the Swedish Market which returned 12.9% over the past year.
Price Volatility
| IMP A SDB volatility | |
|---|---|
| IMP A SDB Average Weekly Movement | 5.2% |
| Medical Equipment Industry Average Movement | 6.9% |
| Market Average Movement | 5.9% |
| 10% most volatile stocks in SE Market | 12.7% |
| 10% least volatile stocks in SE Market | 3.5% |
Stable Share Price: IMP A SDB has not had significant price volatility in the past 3 months.
Volatility Over Time: IMP A SDB's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2015 | 49 | Peter Forsell | www.implantica.com |
Implantica AG engages in the research and distribution of medical implants in Switzerland. The company’s lead product candidate is RefluxStop, a passive CE-marked implant for prevention of gastroesophageal reflux disease. It is also involved in the development of eHealth platform, a digital health system to support its pipeline of smart medical implants designed for a safe and secure control and monitoring over the internet; e-InVivo, a sensor implants to monitor a multitude of health parameters and provide diagnostic information, as well as control treatment from inside the body; wireless energizing platform; and AppetiteControl, an implant to treat obesity by controlling appetite.
Implantica AG Fundamentals Summary
| IMP A SDB fundamental statistics | |
|---|---|
| Market cap | kr8.13b |
| Earnings (TTM) | -kr253.85m |
| Revenue (TTM) | kr19.10m |
425.4x
P/S Ratio-32.0x
P/E RatioIs IMP A SDB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| IMP A SDB income statement (TTM) | |
|---|---|
| Revenue | €1.70m |
| Cost of Revenue | €1.35m |
| Gross Profit | €347.00k |
| Other Expenses | €22.90m |
| Earnings | -€22.56m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 21, 2024
| Earnings per share (EPS) | -0.08 |
| Gross Margin | 20.45% |
| Net Profit Margin | -1,329.17% |
| Debt/Equity Ratio | 0% |
How did IMP A SDB perform over the long term?
See historical performance and comparison